People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Recuro Health, Inc. | — | Healthtech | Series B | $44.2M | $340.0M | 2022 |
Philip Fasano at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip Fasano on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Paiva | 1 | 6 |
| Michael Gorton | 1 | 5 |
| Andrew Holm | 1 | 2 |
| Kimberly Darling | 1 | 1 |
| Kris Engskov | 1 | 1 |
| John Halsey | 1 | 1 |
| Bob Zollars | 1 | 1 |
| Allison Martin | 1 | 1 |
| Tracy Chadwell | 1 | 1 |
| Michael Moradi | 1 | 1 |
| Gina Fioretti | 1 | 1 |
| Michael Brombach | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.